The site is undergoing maintenance on
Thursday, September 10, 7:00 pm through Friday, September 11, 3:00 am (CEST), 2026.
If you encounter problems while ordering, please contact us at BDBCustomerService@bd.com
See More
The site is undergoing maintenance on
Thursday, September 10, 7:00 pm through Friday, September 11, 3:00 am (CEST), 2026.
If you encounter problems while ordering, please contact us at BDBCustomerService@bd.com
See MoreThe site is undergoing maintenance on
Thursday, September 10, 7:00 pm through Friday, September 11, 3:00 am (CEST), 2026
.If you encounter problems while ordering, please contact us at BDBCustomerService@bd.com
This page has been recently translated and is available in French now.
Looks like you're visiting us from {countryName}.
Would you like to stay on the current location site or be switched to your location?
Flow cytometric analysis of CD80 (B7-1) expression on Human Raji cells. Cells from the Human Raji (Burkitt's B cell lymphoma, ATCC® CCL-86™) cell line were preincubated with Human BD Fc Block™ (Cat. No. 564219/564220) and stained with either BD Horizon™ BV421 Mouse IgG1, κ Isotype Control (Cat No. 562438, dashed line histogram) or BD OptiBuild™ BV421 Mouse Anti-Human CD80 (B7-1) [Cat No. 751723; solid line histogram] at 1.0 ug/test. DAPI (4',6-Diamidino-2-Phenylindole, Dihydrochloride) Solution (Cat. No. 564907) was added to cells right before analysis. The fluorescence histogram showing CD80 (B7-1) expression (or Ig Isotype control staining) was derived from gated events with the forward and side light-scatter characteristics of viable (DAPI-negative) Raji cells. Flow cytometry and data analysis were performed using a BD FACSCelesta™ Cell Analyzer System and FlowJo™ software. Data shown on this Technical Data Sheet are not lot specific.
Flow cytometric analysis of CD80 (B7-1) expression on Human Raji cells. Cells from the Human Raji (Burkitt's B cell lymphoma, ATCC® CCL-86™) cell line were preincubated with Human BD Fc Block™ (Cat. No. 564219/564220) and stained with either BD Horizon™ BV421 Mouse IgG1, κ Isotype Control (Cat No. 562438, dashed line histogram) or BD OptiBuild™ BV421 Mouse Anti-Human CD80 (B7-1) [Cat No. 751723; solid line histogram] at 1.0 ug/test. DAPI (4',6-Diamidino-2-Phenylindole, Dihydrochloride) Solution (Cat. No. 564907) was added to cells right before analysis. The fluorescence histogram showing CD80 (B7-1) expression (or Ig Isotype control staining) was derived from gated events with the forward and side light-scatter characteristics of viable (DAPI-negative) Raji cells. Flow cytometry and data analysis were performed using a BD FACSCelesta™ Cell Analyzer System and FlowJo™ software. Data shown on this Technical Data Sheet are not lot specific.
Flow cytometric analysis of CD80 (B7-1) expression on Human Raji cells. Cells from the Human Raji (Burkitt's B cell lymphoma, ATCC® CCL-86™) cell line were preincubated with Human BD Fc Block™ (Cat. No. 564219/564220) and stained with either BD Horizon™ BV421 Mouse IgG1, κ Isotype Control (Cat No. 562438, dashed line histogram) or BD OptiBuild™ BV421 Mouse Anti-Human CD80 (B7-1) [Cat No. 751723; solid line histogram] at 1.0 ug/test. DAPI (4',6-Diamidino-2-Phenylindole, Dihydrochloride) Solution (Cat. No. 564907) was added to cells right before analysis. The fluorescence histogram showing CD80 (B7-1) expression (or Ig Isotype control staining) was derived from gated events with the forward and side light-scatter characteristics of viable (DAPI-negative) Raji cells. Flow cytometry and data analysis were performed using a BD FACSCelesta™ Cell Analyzer System and FlowJo™ software. Data shown on this Technical Data Sheet are not lot specific.
Flow cytometric analysis of CD80 (B7-1) expression on Human Raji cells. Cells from the Human Raji (Burkitt's B cell lymphoma, ATCC® CCL-86™) cell line were preincubated with Human BD Fc Block™ (Cat. No. 564219/564220) and stained with either BD Horizon™ BV421 Mouse IgG1, κ Isotype Control (Cat No. 562438, dashed line histogram) or BD OptiBuild™ BV421 Mouse Anti-Human CD80 (B7-1) [Cat No. 751723; solid line histogram] at 1.0 ug/test. DAPI (4',6-Diamidino-2-Phenylindole, Dihydrochloride) Solution (Cat. No. 564907) was added to cells right before analysis. The fluorescence histogram showing CD80 (B7-1) expression (or Ig Isotype control staining) was derived from gated events with the forward and side light-scatter characteristics of viable (DAPI-negative) Raji cells. Flow cytometry and data analysis were performed using a BD FACSCelesta™ Cell Analyzer System and FlowJo™ software. Data shown on this Technical Data Sheet are not lot specific.
Flow cytometric analysis of CD80 (B7-1) expression on Human Raji cells. Cells from the Human Raji (Burkitt's B cell lymphoma, ATCC® CCL-86™) cell line were preincubated with Human BD Fc Block™ (Cat. No. 564219/564220) and stained with either BD Horizon™ BV421 Mouse IgG1, κ Isotype Control (Cat No. 562438, dashed line histogram) or BD OptiBuild™ BV421 Mouse Anti-Human CD80 (B7-1) [Cat No. 751723; solid line histogram] at 1.0 ug/test. DAPI (4',6-Diamidino-2-Phenylindole, Dihydrochloride) Solution (Cat. No. 564907) was added to cells right before analysis. The fluorescence histogram showing CD80 (B7-1) expression (or Ig Isotype control staining) was derived from gated events with the forward and side light-scatter characteristics of viable (DAPI-negative) Raji cells. Flow cytometry and data analysis were performed using a BD FACSCelesta™ Cell Analyzer System and FlowJo™ software. Data shown on this Technical Data Sheet are not lot specific.
Flow cytometric analysis of CD80 (B7-1) expression on Human Raji cells. Cells from the Human Raji (Burkitt's B cell lymphoma, ATCC® CCL-86™) cell line were preincubated with Human BD Fc Block™ (Cat. No. 564219/564220) and stained with either BD Horizon™ BV421 Mouse IgG1, κ Isotype Control (Cat No. 562438, dashed line histogram) or BD OptiBuild™ BV421 Mouse Anti-Human CD80 (B7-1) [Cat No. 751723; solid line histogram] at 1.0 ug/test. DAPI (4',6-Diamidino-2-Phenylindole, Dihydrochloride) Solution (Cat. No. 564907) was added to cells right before analysis. The fluorescence histogram showing CD80 (B7-1) expression (or Ig Isotype control staining) was derived from gated events with the forward and side light-scatter characteristics of viable (DAPI-negative) Raji cells. Flow cytometry and data analysis were performed using a BD FACSCelesta™ Cell Analyzer System and FlowJo™ software. Data shown on this Technical Data Sheet are not lot specific.
Any use of products other than the permitted use without the express written authorization of Becton, Dickinson and Company is strictly prohibited.
BD® CompBeads can be used as surrogates to assess fluorescence spillover (compensation). When fluorochrome conjugated antibodies are bound to BD® CompBeads, they have spectral properties very similar to cells. However, for some fluorochromes there can be small differences in spectral emissions compared to cells, resulting in spillover values that differ when compared to biological controls. It is strongly recommended that when using a reagent for the first time, users compare the spillover on cells and BD® CompBeads to ensure that BD® CompBeads are appropriate for your specific cellular application.
For optimal and reproducible results, BD Horizon Brilliant Stain Buffer should be used anytime BD Horizon Brilliant dyes are used in a multicolor flow cytometry panel. Fluorescent dye interactions may cause staining artifacts which may affect data interpretation. The BD Horizon Brilliant Stain Buffer was designed to minimize these interactions. When BD Horizon Brilliant Stain Buffer is used in in the multicolor panel, it should also be used in the corresponding compensation controls for all dyes to achieve the most accurate compensation. For the most accurate compensation, compensation controls created with either cells or beads should be exposed to BD Horizon Brilliant Stain Buffer for the same length of time as the corresponding multicolor panel. More information can be found in the Technical Data Sheet of the BD Horizon Brilliant Stain Buffer (Cat. No. 563794/566349) or the BD Horizon Brilliant Stain Buffer Plus (Cat. No. 566385).
The 2D10.4 monoclonal antibody, also known as 2D10, specifically recognizes CD80 which is otherwise known as Activation B7-1 antigen (B7-1), B7.1, or B7. This ~60 kDa single-pass type I transmembrane glycoprotein is encoded by CD80 (CD80 molecule) that belongs to the immunoglobulin gene superfamily (IgSF). CD80 (B7-1) is comprised of an extracellular region with an IgV-like domain followed by an IgC-like domain, a transmembrane region and a cytoplasmic tail. It is variably expressed on activated B cells, activated CD4+ and CD8+ T cells, macrophages, and dendritic cells. CD80 (B7-1) serves as a ligand for the CD28 and CD152 (CTLA-4) coreceptors that are differentially expressed on T cells. CD80 (B7-1) engagement of CD28 costimulates T cells activated through their TCR-CD3 complex whereas its interaction with CD152 (CTLA-4) generates an inhibitory signal for T cell responses.
Please refer to Support Documents for Quality Certificates
Global - Refer to manufacturer's instructions for use and related User Manuals and Technical data sheets before using this products as described
Comparisons, where applicable, are made against older BD Technology, manual methods or are general performance claims. Comparisons are not made against non-BD technologies, unless otherwise noted.
For Research Use Only. Not for use in diagnostic or therapeutic procedures.